1. Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial. Issue 1 (January 2023) Authors: Maher, Toby M; Tudor, Veronica A; Saunders, Peter; Gibbons, Michael A; Fletcher, Sophie V; Denton, Christopher P; Hoyles, Rachel K; Parfrey, Helen; Renzoni, Elisabetta A; Kokosi, Maria; Wells, Athol U; Ashby, Deborah; Szigeti, Matyas; Molyneaux, Philip L; Akil, Mohammed; Babalis, Daphne; Chaudhur... Journal: Lancet Issue: Volume 11:Issue 1(2023) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗